PCMA Challenges D.C.'s PBM "Transparency" Provision In Federal Court
This article was originally published in The Pink Sheet Daily
Executive Summary
The PBM association's arguments against Title II of D.C.'s "AccessRx Act of 2004" mirror those made in a similar case in Maine. PCMA contends that the law, which requires PBMs to disclose financial arrangements with drug manufacturers, is unconstitutional and preempted by ERISA.
You may also be interested in...
Express Scripts CEO Sees Transparency Law Consequences
PBMs are able to secure better prices from manufacturers without transparency, Paz says.
Express Scripts CEO Sees Transparency Law Consequences
PBMs are able to secure better prices from manufacturers without transparency, Paz says.
PCMA To Continue To Fight D.C. PBM Transparency Law
D.C. lawmakers attempt to lift injunction by revising transparency bill to resemble legislation from Maine.